Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 4 studies | 41% ± 9% | |
endothelial cell | 3 studies | 30% ± 18% | |
GABAergic neuron | 3 studies | 31% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 67% | 32.71 | 1782 / 2642 | 2% | 0.09 | 13 / 705 |
ovary | 1% | 0.21 | 2 / 180 | 25% | 1.36 | 109 / 430 |
adrenal gland | 5% | 0.93 | 12 / 258 | 20% | 0.53 | 46 / 230 |
bladder | 10% | 1.14 | 2 / 21 | 14% | 0.67 | 70 / 504 |
uterus | 1% | 0.17 | 2 / 170 | 17% | 1.35 | 78 / 459 |
esophagus | 1% | 0.12 | 10 / 1445 | 17% | 1.39 | 31 / 183 |
skin | 0% | 0.10 | 8 / 1809 | 17% | 1.56 | 81 / 472 |
liver | 0% | 0 | 0 / 226 | 17% | 1.36 | 70 / 406 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.10 | 5 / 29 |
lung | 1% | 0.10 | 3 / 578 | 13% | 0.73 | 147 / 1155 |
stomach | 1% | 0.05 | 2 / 359 | 6% | 0.60 | 17 / 286 |
intestine | 1% | 0.16 | 14 / 966 | 4% | 0.30 | 22 / 527 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.08 | 2 / 45 |
breast | 1% | 0.23 | 6 / 459 | 3% | 0.09 | 33 / 1118 |
pancreas | 0% | 0.04 | 1 / 328 | 3% | 0.10 | 5 / 178 |
prostate | 2% | 0.47 | 6 / 245 | 0% | 0.00 | 1 / 502 |
muscle | 2% | 0.60 | 18 / 803 | 0% | 0 | 0 / 0 |
thymus | 2% | 0.48 | 12 / 653 | 0% | 0.02 | 1 / 605 |
peripheral blood | 2% | 0.34 | 14 / 929 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.02 | 5 / 901 |
spleen | 0% | 0.05 | 1 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.07 | 5 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 0.07 | 3 / 861 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.24 | 4 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000627 | Biological process | positive regulation of miRNA catabolic process |
GO_0050779 | Biological process | RNA destabilization |
GO_2000632 | Biological process | negative regulation of pre-miRNA processing |
GO_0031054 | Biological process | pre-miRNA processing |
GO_0010587 | Biological process | miRNA catabolic process |
GO_2000635 | Biological process | negative regulation of primary miRNA processing |
GO_0031123 | Biological process | RNA 3'-end processing |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | LIN28B |
Protein name | LIN28B protein Protein lin-28 homolog B (Lin-28B) Lin-28 homolog B |
Synonyms | CSDD2 |
Description | FUNCTION: Suppressor of microRNA (miRNA) biogenesis, including that of let-7 and possibly of miR107, miR-143 and miR-200c. Binds primary let-7 transcripts (pri-let-7), including pri-let-7g and pri-let-7a-1, and sequester them in the nucleolus, away from the microprocessor complex, hence preventing their processing into mature miRNA . Does not act on pri-miR21 . The repression of let-7 expression is required for normal development and contributes to maintain the pluripotent state of embryonic stem cells by preventing let-7-mediated differentiation. When overexpressed, recruits ZCCHC11/TUT4 uridylyltransferase to pre-let-7 transcripts, leading to their terminal uridylation and degradation . This activity might not be relevant in vivo, as LIN28B-mediated inhibition of let-7 miRNA maturation appears to be ZCCHC11-independent . Interaction with target pre-miRNAs occurs via an 5'-GGAG-3' motif in the pre-miRNA terminal loop. Mediates MYC-induced let-7 repression (By similarity). When overexpressed, isoform 1 stimulates growth of the breast adenocarcinoma cell line MCF-7. Isoform 2 has no effect on cell growth. . |
Accessions | A0A1B0GVD3 A7E2T3 A0A1B0GTK2 ENST00000345080.5 [Q6ZN17-1] ENST00000635857.1 ENST00000637759.1 Q6ZN17 |